Julia is a qualified pharmacist who joined ICI (later Zeneca and AstraZeneca) in 1988 following a PhD and post Doc in antibody-directed drug delivery at Nottingham University. She spent 8 years providing formulation support to drug discovery teams, trouble shooting issues and delivering novel formulations and biopharmaceutics advice to development project teams with compounds already in man.
From 1996, Julia supported global drug discovery and development teams as the DMPK representative supporting both pre-clinical DMPK and clinical pharmacology and working with compounds from candidate selection stage right through to regulatory filing. She spent three years in senior management with responsibility for clinical pharmacology and DMPK project leaders in the UK and US, driving functional strategy and planning. She also delivered functional portfolio and project advice to the Oncology and Infection Therapy Area Team.
Following a re-organisation in 2011, Julia moved into the projects area as a Clinical Program Director in early Oncology, remaining in this role until she left AstraZeneca in 2015. She designed, developed, secured and managed multi-million dollar budgets for drug development programs from candidate selection, through First in Man and into Phase I/II, delivering studies through external partners and building productive relationships with key investigators and external companies.